Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Overview of attention for article published in Nature Medicine, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 96 news outlets
blogs: 9 blogs

twitter: 54 X users
facebook: 2 Facebook pages

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 25 Mendeley

Summary News Blogs X Facebook Dimensions citations

So far, Altmetric has seen 60 X posts from 54 X users, with an upper bound of 2,930,694 followers.

メンタルヘルス：治療抵抗性のうつ病に経口ケタミン錠が有効 Nature Medicine 2024年6月25日 https://t.co/szGIXaAsm3

10 Jul 2024

Reply Repost Favourite

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial | Nature Medicine https://t.co/gwqXF3nbmH

10 Jul 2024

Reply Repost Favourite

RT @NatureMedicine: A Phase 2 dosing-finding study of an extended-release tablet formulation of #ketamine in patients with treatment-resist…

09 Jul 2024

Reply Repost Favourite

RT @NatureMedicine: A Phase 2 dosing-finding study of an extended-release tablet formulation of #ketamine in patients with treatment-resist…

09 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 56 additional X posts.